Labcorp Holdings LH Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 28.8%+0.9pp | 28.8%+0.9pp | 28.4%+0.5pp | 28.1%+0.1pp | 27.9%+0.1pp | |
| Operating margin | 10.2%+1.9pp | 9.9%+1.6pp | 9.7%— | 8.8%— | 8.3%— | |
| Net margin | 6.7%+1.1pp | 6.3%+0.5pp | 6.2%— | 5.7%— | 5.5%— | |
| EBITDA margin | 15%+1.8pp | 14.8%+1.5pp | 14.6%— | 13.8%— | 13.3%— | |
| Free cash flow margin | 9.8%+1.0pp | 8.6%+0.2pp | 10%+3.4pp | 9.4%+2.5pp | 8.7%+3.3pp | |
| Returns | ||||||
| Return on equity | 11.1%+2.1pp | 10.5%+1.1pp | 10.1%— | 9.3%— | 9%— | |
| Return on assets | 5.1%+0.9pp | 4.8%+0.5pp | 4.6%— | 4.4%— | 4.3%— | |
| Return on invested capital | 9.8%+1.5pp | 9.7%+1.4pp | 9.8%— | 9.3%— | 8.3%— | |
| Efficiency | ||||||
| Asset turnover | 0.8×0.0× | 0.8×0.0× | 0.7×0.0× | 0.8×+0.1× | 0.8×+0.1× | |
| Inventory turnover | 20.4×+0.7× | 19.3×-0.1× | 19.6×+0.2× | 20.4×+1.1× | 19.7×+1.1× | |
| Liquidity | ||||||
| Current ratio | 1.7×-0.1× | 1.4×0.0× | 1.6×+0.1× | 1.5×+0.6× | 1.8×+1.0× | |
| Quick ratio | 1.5×-0.1× | 1.2×-0.1× | 1.4×+0.1× | 1.3×+0.5× | 1.6×+0.8× | |
| Cash ratio | 0.4×+0.2× | 0.2×-0.3× | 0.2×-0.2× | 0.2×+0.2× | 0.2×+0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.8×0.0× | 0.8×-0.1× | 0.7×-0.1× | 0.7×+0.2× | 0.8×+0.3× | |
| Debt-to-assets | 0.4×0.0× | 0.4×0.0× | 0.3×0.0× | 0.3×+0.1× | 0.4×+0.1× | |
| Net debt / EBITDA | 2.9×-0.6× | 2.9×-0.4× | 2.7×— | 2.9×— | 3.5×— | |
| Interest coverage | 6.4×+1.4× | 6.2×+1.0× | 5.7×— | 5.2×— | 5×— | |
| Valuation | ||||||
| Market capitalization | $21.99B+12.9% | $20.8B+8.4% | $23.85B+26.9% | $21.97B+28.4% | $19.48B+6.0% | |
| Enterprise value | $28.24B+10.2% | $26.79B+7.4% | $29.29B+24.1% | $27.37B+31.6% | $25.63B+15.5% | |
| Price / earnings | 23.4×-3.3× | 23.7×-2.0× | 27.9×— | 28.8×— | 26.7×— | |
| Price / sales | 1.6×+0.1× | 1.5×0.0× | 1.7×+0.3× | 1.6×+0.3× | 1.5×0.0× | |
| Price / book | 2.5×+0.2× | 2.4×0.0× | 2.7×+0.4× | 2.6×+0.5× | 2.3×0.0× | |
| EV / EBITDA | 13.3×-1.4× | 13×-1.4× | 14.6×— | 14.7×— | 14.7×— | |
| EV / sales | 2×+0.1× | 1.9×0.0× | 2.1×+0.3× | 2×+0.4× | 1.9×+0.1× | |
| Free cash flow yield | 6.3%+0.4pp | 5.8%+0.1pp | 5.8%+1.3pp | 5.7%+0.8pp | 5.9%+2.3pp | |
| Earnings yield | 4.3%+0.5pp | 4.2%+0.3pp | 3.6%— | 3.5%— | 3.8%— | |
| Dividend yield | 1.1%-0.2pp | 1.2%-0.1pp | 1%-0.3pp | 1.1%-0.3pp | 1.2%-0.1pp | |
| PEG ratio | 0.8×— | 1.4×— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Labcorp Holdings's profit margins?
- Labcorp Holdings (LH) runs a 28.8% gross margin and a 10.2% operating margin, with a 6.7% net margin.
- Where do Labcorp Holdings's ratios come from?
- Every ratio is computed from Labcorp Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
